The ROE as of December 2025 (TTM) for Poniard Pharmaceuticals, Inc. (PARD) is -187.25%

According to Poniard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -187.25%. This represents a change of 169.17% compared to the average of -69.56% of the last 4 quarters.

Poniard Pharmaceuticals, Inc. (PARD) Historical ROE (quarterly & annually)

How has PARD ROE performed in the past?

The mean historical ROE of Poniard Pharmaceuticals, Inc. over the last ten years is -169.76%. The current -187.25% ROE has changed 10.30% with respect to the historical average. Over the past ten years (40 quarters), PARD's ROE was at its highest in in the June 2003 quarter at 26.67%. The ROE was at its lowest in in the March 2006 quarter at -601.56%.

Poniard Pharmaceuticals, Inc. (PARD) ROE by Quarter and Year

Discovering the peaks and valleys of Poniard Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Poniard Pharmaceuticals, Inc. (PARD) Average ROE

How has PARD ROE performed in the past?

The current ROE of Poniard Pharmaceuticals, Inc. (PARD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Poniard Pharmaceuticals, Inc. (PARD) ROE vs. Peers

How is PARD’s ROE compared to its peers?

Poniard Pharmaceuticals, Inc.’s ROE is less than VioQuest Pharmaceuticals, Inc. (1.33%), less than Regenicin, Inc. (11.88%), less than Q BioMed Inc. (44.12%), less than Scopus BioPharma Inc. (911.69%), greater than Strategic Partners A/S (-94.35%), greater than RenovaCare, Inc. (-94.75%), less than Vaxxinity, Inc. (-0.15%), greater than PaxMedica, Inc. Common Stock (-1046.98%), less than NovAccess Global Inc. (76.60%), greater than Aeolus Pharmaceuticals, Inc. (-302.81%),

Build a custom stock screener for Poniard Pharmaceuticals, Inc. (PARD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poniard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poniard Pharmaceuticals, Inc. (PARD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poniard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.